Active, not recruitingPhase 3NCT06144645
A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Foundation for Prader-Willi Research
- Principal Investigator
- Theresa Strong, PhD, LMFTFoundation for Prader-Willi Research
- Intervention
- tVNS, intermittent stimulation(device)
- Enrollment
- 102 enrolled
- Eligibility
- 10-40 years · All sexes
- Timeline
- 2024 – 2027
Study locations (18)
- Stanford University, Palo Alto, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Emory University, Atlanta, Georgia, United States
- Rare Disease Research, Atlanta, Georgia, United States
- University of Iowa, Iowa City, Iowa, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Children's Mercy Kansas City, Kansas City, Missouri, United States
- Maimonides Medical Center, Brooklyn, New York, United States
- NYU Langone Health, Garden City, New York, United States
- Montefiore Medical Center and Albert Einstein College of Medicine, The Bronx, New York, United States
- University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- +3 more locations on ClinicalTrials.gov
Collaborators
RTI International
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06144645 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06420297OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06173531Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.